Treatment of anxiety in benzodiazepine-withdrawn patients

Details Treatment of anxiety in benzodiazepine-withdrawn patients Treatment of anxiety in benzodiazepine-withdrawn patients

A - Human Necessities

61

K

A61K 31/505 (2006.01)

Patent

CA 2081062

Abstract A method of treatment of anxiety in benzodiazepine-withdrawn patients by administering BMY 14802; chemically 4-[4-(5-fluoro-2-pyrimidinyl)-1- piperazinyl]-1-(4-fluorophenyl) butanol, or preferably, the R-(+)- enantiomer to a patient in need of such treatment.

Affiliated with

Also associated with

Rating

Treatment of anxiety in benzodiazepine-withdrawn patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of anxiety in benzodiazepine-withdrawn patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of anxiety in benzodiazepine-withdrawn patients will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2057669